Jacob Smith

13 Apr 2026

Europe’s pharmaceutical sector faces pressure as U.S. trade policies… – Jacob Smith

Europe’s pharmaceutical sector faces pressure as U.S. trade policies under Donald Trump and China’s biotech rise reshape global competition. Declining R&D share and rising tariffs are pushing companies to shift investments, intensifying concerns over Europe’s future role in the global drug industry. #Europe #Pharma #China #USA #TradeWar #Biotech #GlobalEconomy